Aminoadamantanes versus other antiviral drugs for chronic hepatitis C: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Aminoadamantanes Versus Other Antiviral Drugs for Chronic Hepatitis C: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435060/all/Bariatric_surgery_for_non‐alcoholic_steatohepatitis_in_obese_patients_Edited__no_change_to_conclusions_. Accessed 22 September 2023.
Aminoadamantanes versus other antiviral drugs for chronic hepatitis C: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435060/all/Bariatric_surgery_for_non‐alcoholic_steatohepatitis_in_obese_patients_Edited__no_change_to_conclusions_. Accessed September 22, 2023.
Aminoadamantanes versus other antiviral drugs for chronic hepatitis C: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435060/all/Bariatric_surgery_for_non‐alcoholic_steatohepatitis_in_obese_patients_Edited__no_change_to_conclusions_
Aminoadamantanes Versus Other Antiviral Drugs for Chronic Hepatitis C: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2023 September 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435060/all/Bariatric_surgery_for_non‐alcoholic_steatohepatitis_in_obese_patients_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Aminoadamantanes versus other antiviral drugs for chronic hepatitis C: Cochrane systematic review
ID - 435060
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435060/all/Bariatric_surgery_for_non‐alcoholic_steatohepatitis_in_obese_patients_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -